World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
44548
World Ranking
19914
National Ranking
9917

David M. Brown publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David M. Brown sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 160 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David M. Brown D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David M. Brown sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 71 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David M. Brown is affiliated with Houston Methodist in the United States. Their research spans the field of Medicine, with a particular focus on Ophthalmology, contributed by 75 publications. Additional subfields include Radiology, Nuclear Medicine and Imaging, Materials Chemistry, Immunology, and Neurology.

The main research topics covered by David M. Brown involve retinal conditions and treatments. These are detailed as:

  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Retinal and Optic Conditions
  • Glaucoma and retinal disorders
  • Retinal and Macular Surgery
  • Nanoparticles: synthesis and applications
  • Ocular Diseases and Behçet's Syndrome

Their frequent publication venues include:

  • JAMA Ophthalmology
  • Ophthalmology
  • Ophthalmology Retina
  • The Lancet
  • Eye

Notable recent papers by David M. Brown and co-authors include:

  • Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy, 2021, JAMA Ophthalmology
  • Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression, 2022, JAMA Ophthalmology
  • Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders, 2021, Progress in Retinal and Eye Research
  • Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials, 2023, The Lancet
  • TENAYA and LUCERNE, 2024, Ophthalmology

The scientist has collaborated frequently with the following co-authors:

  • Charles C. Wykoff
  • Jeffrey S. Heier
  • David S. Boyer
  • Justis P. Ehlers
  • Vicki Stone

Best Publications

  • Ranibizumab for Neovascular Age-Related Macular Degeneration

    Philip J. Rosenfeld;David M. Brown;Jeffrey S. Heier;David S. Boyer

  • Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

    David M. Brown;Peter K. Kaiser;Mark Michels;Gisele Soubrane

  • Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

    Jeffrey S. Heier;David M. Brown;Victor Chong;Jean Francois Korobelnik

  • Ranibizumab for Diabetic Macular Edema: Results from 2 Phase III Randomized Trials: RISE and RIDE

    Quan Dong Nguyen;David M. Brown;Dennis M. Marcus;David S. Boyer

  • Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

    David M. Brown;Mark Michels;Peter K. Kaiser;Jeffrey S. Heier

  • Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis

    E Pisha;H Chai;I S Lee;T E Chagwedera

  • Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

    David M. Brown;Peter A. Campochiaro;Rishi P. Singh;Zhengrong Li

  • Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1.

    Carl D. Regillo;David M. Brown;Prema Abraham;Huibin Yue

  • Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

    David M. Brown;Quan Dong Nguyen;Dennis M. Marcus;David S. Boyer

  • Intravitreal aflibercept for diabetic macular edema.

    Jean François Korobelnik;Diana V. Do;Ursula Schmidt-Erfurth;David S. Boyer

  • Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration: Ninety-Six–Week Results of the VIEW Studies

    Ursula Schmidt-Erfurth;Peter K. Kaiser;Jean François Korobelnik;David M. Brown

  • HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

    Pravin U Dugel;Adrian Koh;Yuichiro Ogura;Glenn J Jaffe

  • Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.

    David J Browning;Adam R Glassman;Lloyd Paul Aiello

  • Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.

    David M. Brown;Peter A. Campochiaro;Robert B. Bhisitkul;Allen C. Ho

  • Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.

    David M. Brown;Ursula Schmidt-Erfurth;Diana V. Do;Frank G. Holz

  • Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema

    Peter A. Campochiaro;David M. Brown;Andrew Pearson;Sanford Chen

  • ANCHOR STUDY GROUP. RANIBIZUMAB VERSUS VERTEPORFIN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

    D M Brown;P K Kaiser;M Michels;G Soubrane

  • Successful Bone-Marrow Transplantation for Infantile Malignant Osteopetrosis

    Peter F. Coccia;William Krivit;Jaroslav Cervenka;Carlyle Clawson

  • One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema

    Diana V. Do;Quan Dong Nguyen;David Boyer;Ursula Schmidt-Erfurth

  • RANIBIZUMAB FOR PREDOMINANTLY CLASSIC NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: SUBGROUP ANALYSIS OF FIRST-YEAR ANCHOR RESULTS

    Peter K. Kaiser;David M. Brown;Kang Zhang;Henry L. Hudson

Frequent Co-Authors

Peter K. Kaiser
Peter K. Kaiser Cleveland Clinic
Peter A. Campochiaro
Peter A. Campochiaro Johns Hopkins University School of Medicine
Philip J. Rosenfeld
Philip J. Rosenfeld University of Miami
Mark E. Nesbit
Mark E. Nesbit University of Minnesota
George D. Yancopoulos
George D. Yancopoulos Regeneron (United States)
William Krivit
William Krivit University of Minnesota
Theodore R. Oegema
Theodore R. Oegema Rush University Medical Center
Norma K.C. Ramsay
Norma K.C. Ramsay University of Minnesota
Ursula Schmidt-Erfurth
Ursula Schmidt-Erfurth Medical University of Vienna
Frank G. Holz
Frank G. Holz University of Bonn

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine can open doors to a variety of related fields. For those interested in the business side of healthcare, pursuing a health care administration degree can lead to roles in hospital management, policy, or healthcare consulting. These programs are ideal for individuals eager to impact healthcare systems and patient care quality at a managerial level.

Nurses looking to advance their careers might consider specialized bridge programs. The adn to np bridge programs enable registered nurses with associate degrees to become nurse practitioners faster, expanding their scope of practice and earning potential.

Nutrition also plays a vital role in patient well-being. An online nutrition degree can prepare you for careers in dietetics, wellness coaching, or public health, blending scientific knowledge with practical skills for improving lives.

If you’re already working in healthcare and considering further advancement, finding whats the best online mha program for working adults can be crucial. These flexible, accredited programs allow professionals to earn a Master of Health Administration while balancing work and study.

Best Scientists Citing David M. Brown

Trending Scientists

Recently Published Articles